IPO Issue Details
Issue Price / Price Band₹75 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size90 Shares per Lot
Total Issue Size75,00,000 shares (aggregating up to ₹56.25 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 27 Jan 2010
Subscription CloseFri, 29 Jan 2010
Anchor AllotmentTue, 26 Jan 2010
Basis of AllotmentThu, 04 Feb 2010
Initiation of RefundsFri, 05 Feb 2010
Credit of Shares to DematFri, 05 Feb 2010
Listing DateMon, 15 Feb 2010
UPI Mandate Deadline2010-01-29
Application & Investment Details
Retail — Min (1 Lots)₹6,750 — 90 shares
Retail — Max (13 Lots)₹87,750 (13 Lots)
HNI — Min (149 Lots)₹10,05,750 — 13,410 shares
Pre-IPO Promoter Holding1,00,00,000 shares
Post-IPO Promoter Holding1,75,00,000 shares
About Syncom Healthcare Ltd.
Incorporated in 2002, Syncom Healthcare Ltd is a pharmaceutical company based in central India. Syncom is in the business of manufacturing, marketing & trading of pharmaceuticals formulations under its own brands of Ethical, OTC, Generic and Herbal market segment. Syncom have over 250 products available in various dosage forms including Tablets, Capsules, Liquids, Ointments, Eye/Ear Drops, Dry Syrup, Herbal Products, Protein Powder and External Preparations.Apart from their own Marketing setup (OTC, Generics and Ethical Divisions), Syncom Healthcare is also a leading Contract Manufacturing company catering to various domestic and multinational companies. Syncom have a range of over 400 products and can develop customized products as per the needs of the customer and deliver the products at short notice. Syncom Healthcare manufacturing premises spans is over 1,25,000 sq.fts.The proceeds of the issue are proposed to be utilized for its various expansion plan which include setting up of a new manufacturing unit at Indore SEZ for manufacturing various pharmaceutical formulations, undertaking various upgradation/modernization of manufacturing facilities at Dehradun plant and to set up an export office at Mumbai.
Objects of the Issue
Syncom Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 To set up our new manufacturing unit at Indore SEZ
20.480
2
2 To undertake the Upgradation/modernization of manufacturing facilities at Dehradun Plant
6.620
3
3 To meet Working Capital Requirements
15.000
4
4 For opening Export Office at Mumbai
4.000
5
5 For ìBrand & Product Registration and Approvalî
3.000
6
6 General Corporate Purpose
2.923
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,00,00,000 shares
Post-IPO Promoter Holding
1,75,00,000 shares